Skip to main content
. 2020 Apr 27;40(6):844–857. doi: 10.1038/s41372-020-0668-3

Table 3.

Key considerations before introducing a new maternal vaccine [112, 113].

Issue Key considerations
Disease

• Public health and political priorities.

• Alignment with global and regional recommendations.

• Disease burden.

• Status of other disease prevention and control measures.

Vaccine

• Performance and characteristics of available vaccines.

• Economic and financial issues.

• Availability of vaccine supply.

Strength of health system

• Capability and capacity of immunization and maternal health programs, including infrastructure.

• Collaboration between immunization and maternal health programs.

• Continuous implementation of lessons learned.

Optimal timing

• Plans for introducing other new vaccines or maternal health services.

• Opportunities for integration with current disease prevention or health initiatives.